Which Hepatitis types are most commonly seen in intravenous drug users, and what is the vaccine status for these types?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Study for the BIPC Substance Abuse and Disorders Exam. Challenge yourself with a variety of questions to enhance your knowledge and strengthen your preparation. Each question comes with hints and explanations to help you understand and retain crucial information.

Multiple Choice

Which Hepatitis types are most commonly seen in intravenous drug users, and what is the vaccine status for these types?

Explanation:
The main idea tested is which hepatitis types are most linked to intravenous drug use and what their vaccination options look like. Intravenous drug use creates a high risk of bloodborne transmission, so hepatitis B and hepatitis C are the types most commonly seen in this group. Hepatitis B has an effective vaccine that can prevent infection, which is why vaccination is strongly recommended for those at risk. Hepatitis C, on the other hand, has no vaccine available (although antiviral treatments exist), so vaccination cannot prevent C. Among the options, the best match names the two types most associated with IDU and notes that a vaccine is available for the one that can be prevented, while the other has no vaccine. There is also a vaccine for hepatitis A, but it does not change the fact that B and C are the primary pair of concern for IDUs, with the vaccine status aligning with B having a vaccine and C not.

The main idea tested is which hepatitis types are most linked to intravenous drug use and what their vaccination options look like. Intravenous drug use creates a high risk of bloodborne transmission, so hepatitis B and hepatitis C are the types most commonly seen in this group. Hepatitis B has an effective vaccine that can prevent infection, which is why vaccination is strongly recommended for those at risk. Hepatitis C, on the other hand, has no vaccine available (although antiviral treatments exist), so vaccination cannot prevent C.

Among the options, the best match names the two types most associated with IDU and notes that a vaccine is available for the one that can be prevented, while the other has no vaccine. There is also a vaccine for hepatitis A, but it does not change the fact that B and C are the primary pair of concern for IDUs, with the vaccine status aligning with B having a vaccine and C not.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy